Eric L. Simpson
Oregon Health & Science University(US)Henry Ford Hospital(US)Atara Biotherapeutics (United States)(US)University of Bath(GB)
Publications by Year
Research Areas
Dermatology and Skin Diseases, Allergic Rhinitis and Sensitization, Food Allergy and Anaphylaxis Research, Asthma and respiratory diseases, Urticaria and Related Conditions
Most-Cited Works
- → Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis(2016)1,988 cited
- → Eczema Prevalence in the United States: Data from the 2003 National Survey of Children's Health(2010)721 cited
- → Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention(2014)710 cited
- → Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*(2020)563 cited
- → Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults(2016)549 cited
- → Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials